Bivalirudin: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{XXXXX}}
{{Bivalirudin}}
{{CMG}}; {{AE}}
{{CMG}}; {{AE}} {{JH}}


'''''For patient information about XXXXX, click [[XXXXX (patient information)|here]].'''''
'''''For patient information about Bivalirudin, click [[Bivalirudin (patient information)|here]].'''''


{{SB}}
{{SB}}
Line 15: Line 15:
====Label Title====
====Label Title====


'''  [[XXXXX indications and usage|Indications and Usage]]'''
'''  [[Bivalirudin indications and usage|Indications and Usage]]'''
'''| [[XXXXX dosage and administration|Dosage and Administration]]'''
'''| [[Bivalirudin dosage and administration|Dosage and Administration]]'''
'''| [[XXXXX dosage forms and strengths|Dosage Forms and Strengths]]'''
'''| [[Bivalirudin dosage forms and strengths|Dosage Forms and Strengths]]'''
'''| [[XXXXX contraindications|Contraindications]]'''
'''| [[Bivalirudin contraindications|Contraindications]]'''
'''| [[XXXXX warnings and precautions|Warnings and Precautions]]'''
'''| [[Bivalirudin warnings and precautions|Warnings and Precautions]]'''
'''| [[XXXXX adverse reactions|Adverse Reactions]]'''
'''| [[Bivalirudin adverse reactions|Adverse Reactions]]'''
'''| [[XXXXX drug interactions|Drug Interactions]]'''
'''| [[Bivalirudin drug interactions|Drug Interactions]]'''
'''| [[XXXXX use in specific populations|Use in Specific Populations]]'''
'''| [[Bivalirudin use in specific populations|Use in Specific Populations]]'''
'''| [[XXXXX overdosage|Overdosage]]'''
'''| [[Bivalirudin overdosage|Overdosage]]'''
'''| [[XXXXX description|Description]]'''
'''| [[Bivalirudin description|Description]]'''
'''| [[XXXXX clinical pharmacology|Clinical Pharmacology]]'''
'''| [[Bivalirudin clinical pharmacology|Clinical Pharmacology]]'''
'''| [[XXXXX nonclinical toxicology|Nonclinical Toxicology]]'''
'''| [[Bivalirudin nonclinical toxicology|Nonclinical Toxicology]]'''
'''| [[XXXXX clinical studies|Clinical Studies]]'''
'''| [[Bivalirudin clinical studies|Clinical Studies]]'''
'''| [[XXXXX how supplied storage and handling|How Supplied/Storage and Handling]]'''
'''| [[Bivalirudin how supplied storage and handling|How Supplied/Storage and Handling]]'''
'''| [[XXXXX patient counseling information|Patient Counseling Information]]'''
'''| [[Bivalirudin patient counseling information|Patient Counseling Information]]'''
'''| [[XXXXX labels and packages|Labels and Packages]]'''
'''| [[Bivalirudin labels and packages|Labels and Packages]]'''


==Mechanism of Action==
==Mechanism of Action==

Revision as of 10:12, 10 March 2014

Bivalirudin
ANGIOMAX® FDA Package Insert
Indications and Usage
Dosage and Administration
Dosage Forms and Strengths
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Overdosage
Description
Clinical Pharmacology
Nonclinical Toxicology
Clinical Studies
How Supplied/Storage and Handling
Patient Counseling Information
Labels and Packages
Clinical Trials on Bivalirudin
ClinicalTrials.gov

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Jesus Rosario Hernandez, M.D. [2]

For patient information about Bivalirudin, click here.

Synonyms / Brand Names:

Overview

Category

FDA Package Insert

Label Title

Indications and Usage | Dosage and Administration | Dosage Forms and Strengths | Contraindications | Warnings and Precautions | Adverse Reactions | Drug Interactions | Use in Specific Populations | Overdosage | Description | Clinical Pharmacology | Nonclinical Toxicology | Clinical Studies | How Supplied/Storage and Handling | Patient Counseling Information | Labels and Packages

Mechanism of Action

References

Bivalirudin
ANGIOMAX® FDA Package Insert
Indications and Usage
Dosage and Administration
Dosage Forms and Strengths
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Overdosage
Description
Clinical Pharmacology
Nonclinical Toxicology
Clinical Studies
How Supplied/Storage and Handling
Patient Counseling Information
Labels and Packages
Clinical Trials on Bivalirudin
ClinicalTrials.gov